A CASE REPORT: TUMORAL CALCINOSIS IN THE ELBOW REGION
Nội dung chính của bài viết
Tóm tắt
Tumoral calcinosis is a rare condition in clinical practice. We report a clinical case involving an unusually large mass in the elbow region, with postoperative histopathological findings confirming tumoral calcinosis. This case adds to the understanding of the pathogenesis, treatment options, and recurrence rates following surgical intervention.
Chi tiết bài viết
Từ khóa
tumoral calcinosis, soft tissue calcificatio, surgical excision
Tài liệu tham khảo
1. Inclan A., Leon P., Camejo M.G. (1943) Tumoral calcinosis. Journal of the American Medical Association. 121 (7):490-495.
2. Smack D., Norton S.A., Fitzpatrick J.E. (1996) Proposal for a pathogenesis-based classification of tumoral calcinosis. Int J Dermatol. 35 (4):265-71.
3. Topaz O., Indelman M., Chefetz I., et al. (2006) A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis. Am J Hum Genet. 79 (4):759-764.
4. Hershkovitz D., Gross Y., Nahum S., et al. (2011) Functional characterization of SAMD9, a protein deficient in normophosphatemic familial tumoral calcinosis. J Invest Dermatol. 131 (3):662-669.
5. Folsom L.J., Imel E.A. (2015) Hyperphosphatemic familial tumoral calcinosis: genetic models of deficient FGF23 action. Curr Osteoporos Rep. 13 (2):78-87.
6. Andriandi, Husnul F., Tirta C. (2024) Tumoral calcinosis in chronic renal failure: A case report and literature review. Int J Surg Case Rep. 123:110237.
7. Olsen K.M., Chew F.S. (2006) Tumoral calcinosis: pearls, polemics, and alternative possibilities. Radiographics. 26 (3):871-85.
8. André M.O. (2013) Cartilaginous and Osseous Soft Tissue Tumors. In: Practical Soft Tissue Pathology: A Diagnostic Approach, Elsevier, 373-383.
9. Nyree G., Lee A.G. (2013) Soft tissue imaging. In: Grainger & Allison's Diagnostic Radiology Essentials, Elsevier, 546-553.
10. Boyce A.M., Lee A.E., Roszko K.L., et al. (2020) Hyperphosphatemic Tumoral Calcinosis: Pathogenesis, Clinical Presentation, and Challenges in Management. Front Endocrinol (Lausanne). 11:293.

2. Smack D., Norton S.A., Fitzpatrick J.E. (1996) Proposal for a pathogenesis-based classification of tumoral calcinosis. Int J Dermatol. 35 (4):265-71.

3. Topaz O., Indelman M., Chefetz I., et al. (2006) A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis. Am J Hum Genet. 79 (4):759-764.

4. Hershkovitz D., Gross Y., Nahum S., et al. (2011) Functional characterization of SAMD9, a protein deficient in normophosphatemic familial tumoral calcinosis. J Invest Dermatol. 131 (3):662-669.

5. Folsom L.J., Imel E.A. (2015) Hyperphosphatemic familial tumoral calcinosis: genetic models of deficient FGF23 action. Curr Osteoporos Rep. 13 (2):78-87.

6. Andriandi, Husnul F., Tirta C. (2024) Tumoral calcinosis in chronic renal failure: A case report and literature review. Int J Surg Case Rep. 123:110237.

7. Olsen K.M., Chew F.S. (2006) Tumoral calcinosis: pearls, polemics, and alternative possibilities. Radiographics. 26 (3):871-85.

8. André M.O. (2013) Cartilaginous and Osseous Soft Tissue Tumors. In: Practical Soft Tissue Pathology: A Diagnostic Approach, Elsevier, 373-383.

9. Nyree G., Lee A.G. (2013) Soft tissue imaging. In: Grainger & Allison's Diagnostic Radiology Essentials, Elsevier, 546-553.

10. Boyce A.M., Lee A.E., Roszko K.L., et al. (2020) Hyperphosphatemic Tumoral Calcinosis: Pathogenesis, Clinical Presentation, and Challenges in Management. Front Endocrinol (Lausanne). 11:293.
